GEHC Stock Overview
Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
GE HealthCare Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$76.96 |
| 52 Week High | US$94.50 |
| 52 Week Low | US$62.35 |
| Beta | 0 |
| 1 Month Change | -3.56% |
| 3 Month Change | -16.94% |
| 1 Year Change | -4.37% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 28.27% |
Recent News & Updates
Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21
GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02Recent updates
Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited
Feb 14GE HealthCare Q4 Earnings: Growth Lagging The Market
Feb 06Why GE HealthCare May Be Up To 50% Undervalued
Jan 11GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital
Jan 05GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate
Oct 23GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price
Jun 28Some Confidence Is Lacking In GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) P/E
Apr 17Shareholder Returns
| GEHC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.9% | 1.6% | 1.4% |
| 1Y | -4.4% | 4.4% | 23.1% |
Return vs Industry: GEHC underperformed the US Medical Equipment industry which returned 3% over the past year.
Return vs Market: GEHC underperformed the US Market which returned 21.7% over the past year.
Price Volatility
| GEHC volatility | |
|---|---|
| GEHC Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: GEHC has not had significant price volatility in the past 3 months.
Volatility Over Time: GEHC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 51,000 | Pete Arduini | www.gehealthcare.com |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
GE HealthCare Technologies Inc. Fundamentals Summary
| GEHC fundamental statistics | |
|---|---|
| Market cap | US$35.39b |
| Earnings (TTM) | US$1.57b |
| Revenue (TTM) | US$19.50b |
22.3x
P/E Ratio1.8x
P/S RatioIs GEHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GEHC income statement (TTM) | |
|---|---|
| Revenue | US$19.50b |
| Cost of Revenue | US$11.56b |
| Gross Profit | US$7.93b |
| Other Expenses | US$6.36b |
| Earnings | US$1.57b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.45 |
| Gross Margin | 40.69% |
| Net Profit Margin | 8.07% |
| Debt/Equity Ratio | 121.8% |
How did GEHC perform over the long term?
See historical performance and comparison